Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / I••••••••• E•••

L••••••• Acquires I••••••••• E•••

Add-on acquisitionannouncedadd-onannouncement date unknownFact
What happened
Target
I••••••••• E•••
Platform
L•••••••add-on basis: L••••••• was formed by bringing together the expertise and capabilities of several exceptional organizations, including Cello Health, BresMed, Guidemark Health, Cyan Health, and Zipher Medical Affairs, and is backed by A•••••• Capital Partners, a leading middle market private equity firm specializing in building transformative healthcare businesses. | published on A•••••• Capital's own news page
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • L•••••••Platformconfirmed
    “L••••••• was formed by bringing together the expertise and capabilities of several exceptional organizations, including Cello Health, BresMed, Guidemark Health, Cyan Health, and Zipher Medical Affairs, and is backed by A•••••• Capital Partners, a leading middle market private equity firm specializin”
  • A•••••• C•••••• M••••••••• L•Sponsorconfirmed
    “L••••••• was formed by bringing together the expertise and capabilities of several exceptional organizations, including Cello Health, BresMed, Guidemark Health, Cyan Health, and Zipher Medical Affairs, and is backed by A•••••• Capital Partners, a leading middle market private equity firm specializin”
Side not stated
  • J•• W•••••••Managementconfirmed
    “J•• W•••••••, CEO of L•••••••, said, “We are delighted to welcome IE to the L••••••• family, further enhancing our asset optimization and commercialization capabilities.”
  • S•••• M••••Managementconfirmed
    “S•••• M••••, Founder and CEO of IE, said, “We are thrilled to join this exciting and rapidly growing organization.”
  • I••••••••• E•••Targetconfirmed
    “L••••••• today announced the acquisition of I••••••••• E••• (“IE”), a leading provider of pharmaceutical product launch services.”
Evidence
“L••••••• today announced the acquisition of I••••••••• E••• (“IE”), a leading provider of pharmaceutical product launch services.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 17, 2026